Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. - Wikidata - thesis-toulmin - TriplyDB

Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts.

Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts.

http://www.wikidata.org/entity/Q34228938

about

Model-specific selection of molecular targets for heart failure gene therapy Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21 New Delivery Systems of Stem Cells for Vascular Regeneration in Ischemia Angiogenic therapy for coronary artery and peripheral arterial disease.Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts.Basic fibroblast growth factor increased regional myocardial blood flow and limited infarct size of acutely infarcted myocardium in dogs.Pharmacotherapy for end-stage coronary artery disease.The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies.Improved myocardial perfusion and cardiac function by controlled-release basic fibroblast growth factor using fibrin glue in a canine infarct model.p27 kip1 haplo-insufficiency improves cardiac function in early-stages of myocardial infarction by protecting myocardium and increasing angiogenesis by promoting IKK activation Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - on the way to the clinic.Peripheral blood mono-nuclear cells implantation in patients with peripheral arterial disease: a pilot study for clinical and biochemical outcome of neoangiogenesis Animal models of cardiac disease and stem cell therapy.Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart.The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure.Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart Therapeutic angiogenesis for myocardial ischemia.Beyond angiogenesis: the cardioprotective potential of fibroblast growth factor-2.Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor.Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?Gene therapy to treat cardiovascular disease.Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts Therapeutic angiogenesis for myocardial ischemia revisited: basic biological concepts and focus on latest clinical trials.Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success.Heparan sulfate in angiogenesis: a target for therapy.Optimizing the host substrate environment for cardiac angiogenesis, arteriogenesis, and myogenesis.Glucagon-Like Peptide 1 Receptor Activation Augments Cardiac Output and Improves Cardiac Efficiency in Obese Swine After Myocardial Infarction.Heparin-mediated selective release of hepatocyte growth factor in humans.Positive and negative regulation of angiogenesis: from cell biology to the clinic.Angiogenesis and vasculogenesis in treatment of cardiovascular disease.A computational model of fibroblast growth factor-2 binding to endothelial cells under fluid flow.Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent.Sustained Placental Growth Factor-2 Treatment Does Not Aggravate Advanced Atherosclerosis in Ischemic Cardiomyopathy.Delivery of drugs, growth factors, genes and stem cells via intrapericardial, epicardial and intramyocardial routes for sustained local targeted therapy of myocardial disease.A porcine model of ischemic heart failure produced by intracoronary injection of ethyl alcohol.Placental growth factor increases regional myocardial blood flow and contractile function in chronic myocardial ischemia.Effects of different doses of granulocyte colony-stimulating factor mobilization therapy on ischemic cardiomyopathy.Angiogenesis and the heart: therapeutic implications.

P2860

Q26823061-91A0BB69-563B-41CD-AA43-AFDA26463815 Q28084197-9EF20FBF-16BF-41DC-9713-99DE874CE173 Q30361288-F01E7B5C-ABFC-4DDA-89DD-C0EB69E780DA Q30783593-54C79319-B52D-4D0F-802D-58EF188F29DA Q31939873-FEC13EF7-5FD5-4680-A808-42002ADD1219 Q32063516-C460BC78-80C9-4CB1-953B-D48BA650EB1F Q33610142-964C52DB-F0E7-4CE7-ADB9-4AFE0AC430D0 Q33682785-295EA237-31DB-4A67-9752-96C98714335C Q33759629-A911677B-AF3F-45AF-8AE1-1494B5704229 Q34013292-856731BA-6875-4FCF-8DFD-CE1CB3848165 Q34035800-254D656B-9E1A-4BD3-BE8D-CB6A32E97430 Q34319721-755217A5-1AB7-40CB-8D8D-1B6AC59E242B Q34485563-568B34A7-A1A6-4E86-A93C-7CB27053D41D Q34508351-B178CE2F-2906-47EF-B09A-9BF98C3C2648 Q34550233-5F53364D-74F5-4A77-9906-BCC33504704A Q35065245-21CD8E37-5091-4750-BAEA-63055AB8E275 Q35576360-88FB2B80-7962-4EA2-9E47-A25330E9CF96 Q35777375-0BC50D6F-FA1A-48A3-8F03-FE4CE5FB2A03 Q36006513-CF7BF7F7-A634-48EC-BCD3-41AE6E4715BA Q36095572-83585A6B-06A6-4C70-AA51-952B32DE60B1 Q36194967-80AED75E-2CEF-4347-AC3F-5A6A4B4BBED0 Q36707530-51E64EFE-095F-4678-9740-CA1DE87915F5 Q37310450-3B1AD42B-ED89-4297-887F-25934B301839 Q37610441-47BAB5E1-D4AF-4D8A-BD86-E96F052E27EF Q37961586-A21DB8AD-DE6F-4C51-B76B-3D5529A9F6C8 Q38087578-78ED1AF4-DC61-4E04-97FB-48AFD9DD0A9E Q38154506-917B7AAA-6D9A-4DB0-B700-0878C1B5E2AF Q38748690-36C28728-C589-47AB-9A07-788DB8678C15 Q38797077-BF6FAD7D-20A4-41CF-808D-B59A0B1AA2A8 Q41611766-AD788FE8-20B8-4419-893D-6D49B3A12ED5 Q41744346-F3E91533-57E2-4C74-9FC9-F0E71317DDA6 Q41942219-9EB8377B-D60C-446E-BE39-3610C316D341 Q42832445-CBCC52A3-0C01-4419-A4B4-23F708A82987 Q43852677-C780510C-1E99-4A94-813A-C4E4F3B862D8 Q48293024-B2F57565-23D7-4C23-9BAC-2DE7770A25F2 Q50677671-A9D06C8C-9F32-43AB-A1EE-BB44B28EFC30 Q51536482-E6D1B7DB-E66A-4334-8306-B4A3656A1014 Q51838403-28F3A0E5-28DF-4702-9E03-B9469DD57566 Q52590928-9DF93576-4AB5-45A3-8E2F-2E944112F4F3 Q55067118-01562D7F-F485-4EB7-9128-4FB59098E3CA

P2860

Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts.

http://www.wikidata.org/entity/Q34228938

description

1994 nî lūn-bûn

@nan

1994 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Basic fibroblast growth factor ...... cally ischemic porcine hearts.

@ast

Basic fibroblast growth factor ...... cally ischemic porcine hearts.

@en

Basic fibroblast growth factor ...... cally ischemic porcine hearts.

@nl

type

label

Basic fibroblast growth factor ...... cally ischemic porcine hearts.

@ast

Basic fibroblast growth factor ...... cally ischemic porcine hearts.

@en

Basic fibroblast growth factor ...... cally ischemic porcine hearts.

@nl

prefLabel

Basic fibroblast growth factor ...... cally ischemic porcine hearts.

@ast

Basic fibroblast growth factor ...... cally ischemic porcine hearts.

@en

Basic fibroblast growth factor ...... cally ischemic porcine hearts.

@nl

P1433

Q34228938-93CBF5C4-4DEA-41E5-BFE2-1ED891354F6B

P1476

Q34228938-258E14AE-6C55-4407-9831-DB47D3433934

P2093

Q34228938-550A1E18-5BB8-4FC5-A597-61F55617240C

Q34228938-6521419A-EB28-4A27-9ADD-E5A7B7567288

Q34228938-84044827-AD36-4A6A-A358-1278E0D97DEB

Q34228938-88DC9CB1-B042-4732-8000-4232986EF41E

Q34228938-91C2AFB1-6E7F-4548-A39F-A2D16E60ADFD

Q34228938-98B30275-07B8-45E1-A131-65E4C2B4043E

Q34228938-A172B239-3E5D-44A3-A744-A07E42A74245

Q34228938-A2F09223-E378-4B08-9CCF-75ACB34A5826

Q34228938-E1D5DD6F-D63A-45FE-864C-E81CFDA1EADD

P2860

Q34228938-08C11948-1F11-45B6-8CFC-CEE9BA2C82A3

Q34228938-11B40988-7E38-425C-ABDD-4B3C47092BFC

Q34228938-1F9E3FBB-444F-4D92-BAE5-40E7F6D12C0E

Q34228938-2B2C4F9D-1E59-4E66-9A01-11D461B770F5

Q34228938-37C2BF53-AE50-4718-AC04-912A9C342A8B

Q34228938-38CEB3D6-90A4-4827-947F-335E10349D87

Q34228938-38FFAAEE-1770-4B70-888B-9A561A2D79F7

Q34228938-4B8AB0E3-1EAC-4050-9EC9-C1CE074C6154

Q34228938-5394B2F6-15B8-42AF-92D4-EC0E0C54D239

Q34228938-5893F7DF-4D50-4953-8171-B04F2296D8A9

P304

Q34228938-84CD6A37-AFD2-4B75-A14F-4F0143E8A63C

P31

Q34228938-35FC60D9-9EB1-4496-B4F5-C0C6C2EC5BB2

P356

Q34228938-7547433D-279D-4E62-AA21-CCA11F9ECB17

P407

Q34228938-75DEE11F-61F8-4812-8D24-905EF616DCD6

P433

Q34228938-31DB2AF5-74F4-4A65-917A-446206A1D998

P478

Q34228938-FC5CDB4F-C2D5-4837-B5A1-A246B88BDBDC

P577

Q34228938-BA41FE6E-A78F-46B4-88AA-7A7B68AEEA9B

P5875

Q34228938-C417C8D2-FC6E-4F6A-B90B-454713367B4F

P698

Q34228938-FBE7E3A1-B20E-4D6D-A8DC-B5E4C9BCD0A3

P932

Q34228938-DB6EAC1F-1227-4516-BADE-23A19409CACC

P356

P1433

Journal of Clinical Investigation

P1476

Basic fibroblast growth factor ...... cally ischemic porcine hearts.

@en

P2093

C S Keighley

http://www.w3.org/2001/XMLSchema#string

E R Edelman

http://www.w3.org/2001/XMLSchema#string

F W Sellke

http://www.w3.org/2001/XMLSchema#string

K Harada

http://www.w3.org/2001/XMLSchema#string

M Friedman

http://www.w3.org/2001/XMLSchema#string

M Simons

http://www.w3.org/2001/XMLSchema#string

P V Prasad

http://www.w3.org/2001/XMLSchema#string

W Grossman

http://www.w3.org/2001/XMLSchema#string

W J Manning

http://www.w3.org/2001/XMLSchema#string

P2860

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

Isolation, characterization, and localization of heparin-binding growth factors in the heart

Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries.

Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix.

Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor

Interactions of FGFs with target cells.

Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions.

Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries.

Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth.

A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane.

P304

623-630

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI117378

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

1994-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15679947

http://www.w3.org/2001/XMLSchema#string

P698

7518840

http://www.w3.org/2001/XMLSchema#string

P932

296139

http://www.w3.org/2001/XMLSchema#string